AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 136.72 |
Market Cap | 21.61B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -9.97 |
PE Ratio (ttm) | -13.67 |
Forward PE | n/a |
Analyst | Hold |
Ask | 139.02 |
Volume | 2,624,105 |
Avg. Volume (20D) | 1,990,595 |
Open | 145.25 |
Previous Close | 144.22 |
Day's Range | 136.26 - 153.06 |
52-Week Range | 97.36 - 156.66 |
Beta | undefined |
About ILMN
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...
Analyst Forecast
According to 17 analyst ratings, the average rating for ILMN stock is "Hold." The 12-month stock price forecast is $152, which is an increase of 11.54% from the latest price.
Next Earnings Release
Analysts project revenue of $1.07B, reflecting a -4.63% YoY shrinking and earnings per share of 0.92, making a 557.14% increase YoY.
21 hours ago · seekingalpha.com
Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)Illumina, Inc. (NASDAQ:ILMN ) 43rd Annual JPMorgan Healthcare Conference Call January 14, 2025 12:00 PM ET Company Participants Jacob Thaysen - Chief Executive Officer Ankur Dhingra - Chief Financial ...
4 weeks ago · businesswire.com
Ovation.io and Illumina Collaborate to Advance Genomic Data ResearchPORTLAND, Maine--(BUSINESS WIRE)--Ovation.io, Inc., an organization dedicated to building best in class multi-omics datasets, today announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), a glob...